These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7628589)

  • 1. Effectiveness of 2-chlorodeoxyadenosine in nodal and extra haematopoietic localizations in hairy cell leukaemia.
    Rieux C; Bastion Y; Bazin M; Dumontet C; Coiffier B; Felman P; Bryon PA
    Eur J Haematol; 1995 Aug; 55(2):133-5. PubMed ID: 7628589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow granulomas in hairy cell leukaemia following 2-chlorodeoxyadenosine therapy.
    Franco V; Florena AM; Quintini G; Musso M
    Histopathology; 1994 Mar; 24(3):271-3. PubMed ID: 7911119
    [No Abstract]   [Full Text] [Related]  

  • 4. Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.
    Zenhäusern R; Von Rohr A; Rufibach K; Solenthaler M; Meyer-Monard S; Gratwohl A; Hess U; Bargetzi MJ; Kovacsovic T; Leoncini L; Tobler A;
    Leuk Lymphoma; 2009 Jan; 50(1):133-6. PubMed ID: 19152171
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K; Zák P
    Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hairy-cell leukaemia as a model for drug development.
    Carson DA; Leoni LM
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):83-9. PubMed ID: 12670467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia.
    Ellison DJ; Sharpe RW; Robbins BA; Spinosa JC; Leopard JD; Saven A; Piro LD
    Blood; 1994 Dec; 84(12):4310-5. PubMed ID: 7994047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapies.
    Pileri S; Sabattini E; Poggi S; Merla E; Raspadori D; Benfenati D; Rondelli D; Benni M; Ventura MA; Falini B
    Leuk Lymphoma; 1994; 14 Suppl 1():67-71. PubMed ID: 7820056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.
    Hakimian D; Tallman MS; Kiley C; Peterson L
    Blood; 1993 Sep; 82(6):1798-802. PubMed ID: 7691237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
    Raanani P; Shpilberg O; Ben-Bassat I
    Harefuah; 1994 Jun; 126(11):673-6. PubMed ID: 7927005
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
    Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine.
    Robak T; Błasińska-Morawiec M; Krykowski E
    Acta Haematol Pol; 1992; 23(4):285-90. PubMed ID: 1363455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index.
    Tallman MS; Hakimian D; Dyrda S; Kiley C; Nemcek A; Peterson L
    Leuk Lymphoma; 1994; 14 Suppl 1():133-8. PubMed ID: 7529609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).
    Zenhäusern R; Simcock M; Gratwohl A; Hess U; Bargetzi M; Tobler A;
    Haematologica; 2008 Sep; 93(9):1426-8. PubMed ID: 18603561
    [No Abstract]   [Full Text] [Related]  

  • 17. Excellent outcome of hairy cell leukaemia with extensive mesenteric infiltration following cladribine therapy.
    Juárez Salcedo LM; Sandoval-Sus J; Zhang L; Klippenstein D; Chavez JC
    Br J Haematol; 2016 Sep; 174(5):659. PubMed ID: 27391097
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose cladribine for symptomatic hairy cell leukaemia.
    Juliusson G; Lenkei R; Tjønnfjord G; Heldal D; Liliemark J
    Br J Haematol; 1995 Mar; 89(3):637-9. PubMed ID: 7734367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukaemia-variant: Disease features and treatment.
    Matutes E; Martínez-Trillos A; Campo E
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.